Search

everythinglearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

5% minoxidil foam effectively treats female hair loss.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

Scalp cooling effectively reduces hair loss from chemotherapy.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.